Isosulfan blue 1% vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBT7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,862
Award facts
- Contract value 100% obligated
- $14,861.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $14,861.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isosulfan Blue 1% in 5ml vials. The delivery order was awarded on December 31, 2025, with an ultimate completion date of January 2, 2026, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier within the federal military medical supply chain, with multiple delivery orders issued by DLA's Medical Supply Chain division since October 2025. The company's comprehensive product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations globally. The PPV-G GEN V program represents DLA's broader $30.3 billion acquisition strategy to establish regional prime vendor contractors capable of fulfilling diverse and specialized pharmaceutical requirements across military healthcare facilities worldwide. This specific delivery order for Isosulfan Blue, a diagnostic agent commonly used in lymphatic mapping procedures, reflects the routine supply activities conducted under the larger prime vendor contract structure.
Quick answers
Who was awarded contract SPE2DR26FFBT7?
SPE2DR26FFBT7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FFBT7 worth?
The government has obligated $14,862 on SPE2DR26FFBT7.
Is contract SPE2DR26FFBT7 an order under another contract?
Yes. SPE2DR26FFBT7 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBT7 competed?
The extent of competition for SPE2DR26FFBT7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award